In vivo models of B-cell lymphoma and colorectal cancer demonstrated that melphalan causes immunogenic cell death, determined by surface-exposed calreticulin and release of high-mobility group box 1 (HMGB1) [197]. Here, CALR is linked to colorectal cancer.